Hirshberg Foundation for Pancreatic Cancer Research

Dedicated to advancing pancreatic cancer research and providing support to patients and their families.

Donate
  • ABOUT THE FOUNDATION
    • Agi’s Story
    • About Us →
      • Mission
      • Directors/Trustees
      • Scientific Advisory Board
      • How Our Journey Began
    • News →
      • Latest News
      • Research News
      • Foundation News
      • UCLA Activity Summary Reports
      • Newsletters
      • Press Room
    • Contact
  • PANCREATIC CANCER
    • About the Pancreas →
      • The Pancreas
      • Cancer Cells
      • Risk Factors
      • Symptoms
      • Diagnosis
      • Prognosis
      • Staging
      • Second Opinion
    • Treatment Options →
      • Surgery
      • Chemotherapy
      • Targeted Therapy
      • Radiation Therapy
      • Alternative Treatment Options
      • Clinical Trials
    • Supportive Care →
      • Obstructions
      • Pain Control
      • Nutrition
      • Cannabis
      • Palliative Care
    • Pancreatic Cancer Facts
    • Glossary of Terms
    • Frequently Asked Questions
  • RESEARCH
    • Seed Grant Program →
      • Seed Grant Recipients
      • Frequently Asked Questions
    • Seed Grant News
    • UCLA Program →
      • UCLA Center for Pancreatic Diseases
      • Basic Research
      • Translational Research
      • Sahin-Toth Laboratory
      • UCLA Pancreas Tissue Bank
      • UC Pancreatic Cancer Consortium
      • Simms/Mann Psychosocial →
        • Insights into Cancer
    • American Pancreatic Association
    • NIH Funded Projects
  • PATIENTS & CAREGIVERS
    • Patient Support
    • Where to Begin
    • Caregivers & Families
    • Symposium →
      • Symposium Presentations
    • Patient & Family Webinars
    • Genetic Counseling
    • Resources →
      • NCCN Guidelines for Patients
      • Patient Support Tools
      • Create Your Health Care Team
      • Patient Health Diaries
      • Support Groups
      • Financial Aid
  • HOW YOU CAN HELP
    • Planned Giving
    • Donor-Advised Funds
    • Event Calendar
    • Get Inspired
    • Fundraising Resources
    • November Awareness Month →
      • World Pancreatic Cancer Day
    • More Ways to Give →
      • You Can Help Funds
      • Host Your Own Event
      • Shop Online Store
      • Wedding Program
      • Volunteer
      • Car Program
  • SEARCH
Home / Symposium Speaker Spotlight / Symposium Speaker Spotlight: Wendy Conlon to discuss Genetic Counseling

Symposium Speaker Spotlight: Wendy Conlon to discuss Genetic Counseling

Wendy Conlon to address the importance of seeing a genetic counselor at the 15th Annual Symposium on Pancreatic Cancer

February 13, 2019

The Hirshberg Foundation is happy to announce that genetic counselor, Wendy Conlon, will be joining us at the 15th Annual Symposium on Pancreatic Cancer to discuss the importance of genetic counseling.

Wendy Conlon, MS, CGC, is a genetic counselor board certified by the American Board of Genetic Counseling and licensed in California. She received her MS in genetics from the University of Arizona’s genetic counseling program in 2000, and received her BA from the University of Vermont in 1988. Before attending graduate school, she worked in a laboratory at the University of Vermont Cancer Center and performed genetic testing for hereditary cancer predisposition for Lynch syndrome, retinoblastoma, Li-Fraumeni syndrome and others. Prior to coming to UCLA, her career as a genetic counselor has included over 12 years in the biotechnology industry working with physicians, scientists and patients in the development and provision of genetic testing, focusing on hereditary cancer and endocrinology. She has also worked as a clinical genetic counselor in varied settings, including adult cancer genetics, assisted reproductive technology and prenatal and preconception genetics.

Wendy is currently one of two genetic counselors that are part of the Integrated Practice Unit (IPU) at the UCLA Agi Hirshberg Center for Pancreatic Diseases. With approximately 5 to 10 percent of pancreatic cancers linked to an inherited cancer predisposition, the IPU offers genetic testing and counseling. A genetic counselor can assess the likelihood that pancreatic cancer in a family is due to an inherited mutation and help to understand personal and family history with pancreatic, and all cancers. Results from genetic testing may also be used to devise tailored surveillance and risk reduction strategies for at-risk family members.

A highly requested topic, we are excited to have Wendy joining us to discuss the topic of Why Should I See A Genetic Counselor? at the 15th Annual Symposium.

image_pdfimage_print

Filed Under: News, Symposium Speaker Spotlight

Symposium Speaker Spotlight: Dr. Joe Hines to discuss Personalized Medicine & Tumor Testing
New Publication by Seed Grant Awardees from UCLA

Patient Support Resources

from the comfort of your home


Our Webinar Library »

Never Give Up.
The journey continues with an end in sight.
Our Stories »
SUBSCRIBE
Our Free E-Newsletter
Sign up to receive information on breaking news, patient programs and upcoming events.
You can custom tailor your subscriptions and unsubscribe at any time.
  • How You Can Help
  • Make A Donation
  • Host an Event
  • Shop Online Store
  • Signature Events
  • L.A. Cancer Challenge
  • Tour De Pier
  • Hirshberg Training Team
  • More
  • News
  • Press
  • Contact

Stay Connected

Join Our E-newsletter

  • Legal and Privacy
  • Financial Information
  • Contact